Intervention Review

Phosphodiesterase five inhibitors for pulmonary hypertension

  1. Parthipan Kanthapillai1,*,
  2. Toby J Lasserson2,
  3. E. Haydn Walters3

Editorial Group: Cochrane Airways Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 12 OCT 2005

DOI: 10.1002/14651858.CD003562.pub2

Database Title

Additional Information

How to Cite

Kanthapillai P, Lasserson TJ, Walters EH. Phosphodiesterase five inhibitors for pulmonary hypertension. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD003562. DOI: 10.1002/14651858.CD003562.pub2.

Author Information

  1. 1

    Luton and Dunstable NHS Trust, Luton, Bedfordshire, UK

  2. 2

    St George's, University of London, Community Health Sciences, London, UK

  3. 3

    University of Tasmania Medical School, Discipline of Medicine, Hobart, Tasmania, Australia

*Parthipan Kanthapillai, Luton and Dunstable NHS Trust, Lewsey Road, Luton, Bedfordshire, LU4 0DZ, UK. Parthipan.Pillai@ldh.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (230K)Full (290K)

  1. Current Version

    Phosphodiesterase five inhibitors for pulmonary hypertension

    Parthipan Kanthapillai, Toby J Lasserson and E. Haydn Walters

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD003562.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Sildenafil for pulmonary hypertension

    P Kanthapillai and EH Walters

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD003562

View Full Article (HTML) Summary (58K)Standard (230K)Full (290K)